Skip to main content
5 min read
◆ Mixed look for TalaricoElections / Campaigns

Crockett's proxy win over Talarico shines spotlight on Texas rivalry

Talarico’s endorsement of Johnson placed him opposite Crockett in the House primary and the article examines his effort to build general-election support.

Crockett's proxy win over Talarico shines spotlight on Texas rivalry
Image · TheGrio

SOURCE CHECK

TAP FOR WHY
Outlet credibilityTheGrio72/100 HIGH
This article1 analysis · Oct 6, 2026
TheGrio
May 27, 2026
tl;dr

Jasmine Crockett endorsed Colin Allred in a Texas House primary, while James Talarico backed Julie Johnson, renewing attention to their Senate-primary rivalry. The article examines how that dispute could affect Talarico’s effort to win support from Black voters in the general election.

Community verdict

15 VOTES
How does this story look for
● OPEN

People in this story

SWIPE →

Texas Senate candidate who endorsed Julie Johnson

PRIMARY SUBJECT

U.S. representative and former Senate candidate who endorsed Colin Allred

Crockett's version of this story ↗
Julie Johnson
D · TX-32

U.S. representative and losing Democratic primary candidate

Ken Paxton
R · TX

Republican Senate nominee opposing Talarico

Colin Z. Allred
Former U.S. Representative (D-TX)

Democratic nominee for Texas’s 32nd Congressional District

ALSO MENTIONED  Barack Obama, Former president who campaigned with Talarico; Zoe Cadore, Political consultant and former congressional candidate

Part of a bigger story

14 OUTLETS
James Talarico Opens Texas Senate Campaign With Focus on Paxton

The outlets identify James Talarico as a candidate in the Texas Senate race. Left-leaning outlets focus on Trump’s recycled insult and its history. Center outlets describe Talarico’s campaign launch and his focus on Paxton’s record, while one article also examines his rivalry with Crockett. Right-leaning outlets present objections to Talarico’s religious teaching as grounds for Christian voters to reject him and favor Paxton.

Discussion · 0

What's your take?

Loading comments…